| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And GC
1 company
Baity Glenn is an EVP And GC at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2018 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sell | 36,558 | $32.39 | $1,184,055.13 | -30.4% | |
| Jan 2, 2018 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 74,321 | $30.14 | $2,240,138.99 | -51.5% | |
| Oct 5, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 37,500 | $40.91 | $1,534,042.50 | -35.0% | |
| Aug 30, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 26,507 | $34.87 | $924,314.99 | -28.2% | |
| Aug 9, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 14,322 | $34.88 | $499,534.17 | -15.6% | |
| Jul 20, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 38,097 | $30.00 | $1,142,910.00 | -34.9% | |
| Jun 22, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 1,903 | $30.00 | $57,090.76 | -2.3% | |
| Feb 14, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 26,365 | $39.66 | $1,045,517.26 | -28.2% | |
| Feb 1, 2017 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 31,078 | $35.15 | $1,092,382.38 | -31.7% | |
| Dec 27, 2016 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 9,800 | $30.46 | $298,473.70 | -12.0% |